Levocarnitine for vismodegib-associated muscle spasms: A pilot randomized, double-blind, placebo-controlled, investigator-initiated trial

被引：0
|
作者：
Chang, Anne Lynn [1 ]
Cannon, John [1 ]
Tran, Duy [1 ]
Li, Shufeng [1 ]
机构：
[1] Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 79卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
7020
引用
收藏
页码：AB178 / AB178
页数：1
相关论文
共 50 条
  • [1] Levocarnitine for vismodegib-associated muscle spasms: a pilot randomized, double-blind, placebo-controlled, investigator-initiated trial
    Cannon, J. G. D.
    Tran, D. C.
    Li, S.
    Chang, A. S.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (07) : E298 - E299
  • [2] A randomized, double-blind, placebo-controlled crossover trial of levocarnitine for vismodegib-associated muscle spasms (NCT1893892)
    Cannon, J. G. D.
    Tran, D. C.
    Li, S.
    Chang, A. L. S.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S51 - S51
  • [3] Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial
    Goldsmith, Scott R.
    Covut, Fahrettin
    Fiala, Mark
    Xiang, Zhifu
    Iqbal, Zahid
    Moore, Nathan
    Bradtke, Elizabeth
    Christen, Brandon
    Rettig, Michael P.
    Christ, Stephanie
    Gehrs, Leah
    Street, Emily
    Wallace, Nicholas
    Ritchey, Julie
    Gao, Feng
    Pachter, Jonathan
    Parikh, Bijal
    Dubberke, Erik R.
    Dipersio, John F.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (11):
  • [4] Duvelisib for Critically-Ill Patients with COVID-19 Disease: An Investigator-Initiated, Randomized, Placebo-Controlled Double-Blind Pilot Trial
    Goldsmith, Scott R.
    Covut, Fahrettin
    Fiala, Mark A.
    Bradtke, Elizabeth
    Gasanli, Ayan
    Christen, Brandon
    Pachter, Jonathan A.
    Xiang, Zhifu
    Iqbal, Zahid
    Moore, Nathan
    Ofoma, Uchenna
    Parikh, Bijal
    Dubberke, Erik
    DiPersio, John F.
    [J]. BLOOD, 2022, 140 : 11185 - 11186
  • [5] Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
    Ebata, Satoshi
    Yoshizaki, Ayumi
    Oba, Koji
    Kashiwabara, Kosuke
    Ueda, Keiko
    Uemura, Yukari
    Watadani, Takeyuki
    Fukasawa, Takemichi
    Miura, Shunsuke
    Yoshizaki-Ogawa, Asako
    Asano, Yoshihide
    Okiyama, Naoko
    Kodera, Masanari
    Hasegawa, Minoru
    Sato, Shinichi
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (07): : E489 - E497
  • [6] ABATACEPT FOR IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS (ATRIUM): A PHASE 3, INVESTIGATOR-INITIATED, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL
    Reynolds, Kerry
    Mooradian, Meghan
    Zlotoff, Daniel
    Ridker, Paul
    Neilan, Tomas
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A727 - A727
  • [7] The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
    Vermeersch, Kristina
    Gabrovska, Maria
    Deslypere, Griet
    Demedts, Ingel K.
    Slabbynck, Hans
    Aumann, Joseph
    Ninane, Vincent
    Verleden, Geert M.
    Troosters, Thierry
    Bogaerts, Kris
    Brusselle, Guy G.
    Janssens, Wim
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 687 - 696
  • [8] Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
    Khanna, Dinesh
    Spino, Cathie
    Johnson, Sindhu
    Chung, Lorinda
    Whitfield, Michael L.
    Denton, Christopher P.
    Berrocal, Veronica
    Franks, Jennifer
    Mehta, Bhavan
    Molitor, Jerry
    Steen, Virginia D.
    Lafyatis, Robert
    Simms, Robert W.
    Gill, Anna
    Kafaja, Suzanne
    Frech, Tracy M.
    Hsu, Vivien
    Domsic, Robyn T.
    Pope, Janet E.
    Gordon, Jessica K.
    Mayes, Maureen D.
    Schiopu, Elena
    Young, Amber
    Sandorfi, Nora
    Park, Jane
    Hant, Faye N.
    Bernstein, Elana J.
    Chatterjee, Soumya
    Castelino, Flavia, V
    Ajam, Ali
    Wang, Yue
    Wood, Tammara
    Allanore, Yannick
    Matucci-Cerinic, Marco
    Distler, Oliver
    Singer, Ora
    Bush, Erica
    Fox, David A.
    Furst, Daniel E.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 (01) : 125 - 136
  • [9] Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial
    Schmitt, J.
    Schaekel, K.
    Foelster-Holst, R.
    Bauer, A.
    Oertel, R.
    Augustin, M.
    Aberer, W.
    Luger, T.
    Meurer, M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (03) : 661 - 668
  • [10] Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis-Results of Phase I/II Investigator-Initiated, Double-Blind Randomized Placebo-Controlled Trial
    Khanna, Dinesh
    Bush, Erica
    Nagaraja, Vivek
    Koenig, Andrew
    Khanna, Puja
    Young, Amber
    Moore, Jeffrey
    Fox, David
    Lafyatis, Robert
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345